David Happel

Director & President & CEO

Director & President & CEO at Sagimet Biosciences Inc., filing insider transactions on 2026-07-20.

Total Purchases

—

0 transactions

Total Sales

$497K

1 transaction

Companies Traded

1 total filings

Active Since

2026-07-20

Last: 2026-07-20

Companies

Sagimet Biosciences Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-07-20	SGMT	Sale	64.1K	$7.76	$497K	741.6K	SEC ↗